Literature DB >> 10220812

Examining the debate on the use of medical marijuana.

R L DuPont1.   

Abstract

The opium poppy and the coca leaf offer useful perspectives on the current controversies over medical marijuana. In both cases, purified synthetic analogues of biologically active components of ancient folk remedies have become medical mainstays without undermining efforts to reduce nonmedical drug use. A decade ago, a campaign strove to legalize heroin for the compassionate treatment of pain in terminally ill patients. Like the current campaign to legalize medical marijuana, many well-meaning people supported this effort. The campaign for medical heroin was stopped by science when double-blind studies showed that heroin offered no benefits over the standard opioid analgesics in the treatment of severe cancer pain. Scientific medicine requires purified chemicals in carefully controlled doses without contaminating toxic substances. That a doctor would one day write a prescription for leaves to be burned is unimaginable. The Controlled Substances Act and international treaties limit the use of abused drugs or medicines. In contrast to smoked marijuana, specific chemicals in marijuana or, more likely, synthetic analogues, may prove to be of benefit to some patients with specific illnesses. Most opponents of medical use of smoked marijuana are not hostile to the medical use of purified synthetic analogues or even synthetic tetrahydrocannabinol (THC), which has been available in the United States for prescription by any licensed doctor since 1985. In contrast, most supporters of smoked marijuana are hostile to the use of purified chemicals from marijuana, insisting that only smoked marijuana leaves be used as "medicine," revealing clearly that their motivation is not scientific medicine but the back door legalization of marijuana.

Entities:  

Mesh:

Year:  1999        PMID: 10220812     DOI: 10.1046/j.1525-1381.1999.09252.x

Source DB:  PubMed          Journal:  Proc Assoc Am Physicians        ISSN: 1081-650X


  3 in total

Review 1.  In the weeds: a baseline view of cannabis use among legalizing states and their neighbours.

Authors:  Rosalie Liccardo Pacula; Mireille Jacobson; Ervant J Maksabedian
Journal:  Addiction       Date:  2016-01-26       Impact factor: 6.526

Review 2.  Medical marijuana initiatives : are they justified? How successful are they likely to be?

Authors:  Wayne Hall; Louisa Degenhardt
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 3.  Benefits and harms of medical cannabis: a scoping review of systematic reviews.

Authors:  Misty Pratt; Adrienne Stevens; Micere Thuku; Claire Butler; Becky Skidmore; L Susan Wieland; Mark Clemons; Salmaan Kanji; Brian Hutton
Journal:  Syst Rev       Date:  2019-12-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.